Gene · 3482
Papers4,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms regulating the intracellular trafficking and release of CLN5 and CTSD. | Traffic | 2024 | 38272448 | PubTator, text mining | PubMed |
| Joint transcriptomic and cytometric study of children with peanut allergy reveals molecular and cellular cross talk in reaction thresholds. | J Allergy Clin Immunol | 2024 | 38272374 | PubTator, text mining | PubMed |
| From PROTAC to TPD: Advances and Opportunities in Targeted Protein Degradation. | Pharmaceuticals (Basel) | 2024 | 38256933 | PubTator, text mining | PubMed |
| Network Proteins of Human Sortilin1, Its Expression and Targetability Using Lycopene. | Life (Basel) | 2024 | 38255751 | PubTator, text mining | PubMed |
| PLCG2 and IFNAR1: The Potential Biomarkers Mediated by Immune Infiltration and Osteoclast Differentiation of Ankylosing Spondylitis in the Peripheral Blood. | Mediators Inflamm | 2024 | 38223749 | PubTator, text mining | PubMed |
| OXR1 maintains the retromer to delay brain aging under dietary restriction. | Nat Commun | 2024 | 38212606 | PubTator, text mining | PubMed |
| Loss of the HOPS complex disrupts early-to-late endosome transition, impairs endosomal recycling and induces accumulation of amphisomes. | Mol Biol Cell | 2024 | 38198575 | PubTator, text mining | PubMed |
| Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways. | Biomark Res | 2024 | 38191508 | PubTator, text mining | PubMed |
| Maternal uniparental disomy for chromosome 6 in 2 prenatal cases with IUGR: case report and literature review. | Mol Cytogenet | 2024 | 38173004 | PubTator, text mining | PubMed |
| Quantifying negative selection in human 3' UTRs uncovers constrained targets of RNA-binding proteins. | Nat Commun | 2024 | 38168060 | PubTator, text mining | PubMed |
Secreted insulin-like growth factor binding protein 5 functions as a tumor suppressor and chemosensitizer through inhibiting insulin-like growth factor 1 receptor/protein kinase B pathway in acute myeloid leukemia. | Neoplasia | 2024 | 38159363 | PubTator, text mining | PubMed |
| Targeted Degradation of Signal Transduction and Activator of Transcription 3 by Chaperone-Mediated Autophagy Targeting Chimeric Nanoplatform. | ACS Nano | 2024 | 38157218 | PubTator, text mining | PubMed |
| Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance. | RNA Biol | 2024 | 38113132 | PubTator, text mining | PubMed |
| Alterations in sperm DNA methylation may as a mediator of paternal air pollution exposure and offspring birth outcomes: Insight from a birth cohort study. | Environ Res | 2024 | 38103775 | PubTator, text mining | PubMed |
| Cation-independent mannose 6-phosphate receptor: From roles and functions to targeted therapies. | J Control Release | 2024 | 38086445 | PubTator, text mining | PubMed |
| Insulin-like Growth Factor 2-Tagged Aptamer Chimeras (ITACs) Modular Assembly for Targeted and Efficient Degradation of Two Membrane Proteins. | Angew Chem Int Ed Engl | 2024 | 38059276 | PubTator, text mining | PubMed |
| Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental disorders, agammaglobulinemia, and premature death. | J Clin Invest | 2024 | 37943617 | PubTator, text mining | PubMed |
| Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome. | Turk J Med Sci | 2023 | 38813031 | PubTator, text mining | PubMed |
| Topical Insulin in Neurotrophic Keratopathy: A Review of Current Understanding of the Mechanism of Action and Therapeutic Approach. | Pharmaceutics | 2023 | 38276493 | PubTator, text mining | PubMed |
| Recent insights into the functions and mechanisms of antisense RNA: emerging applications in cancer therapy and precision medicine. | Front Chem | 2023 | 38274897 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3482/papers?page=10